Potomac Capital Management’s Statera Biopharma STAB Stock Holding History
Bought
Maintained
Sold
Other funds holding STAB
Potomac Capital Management's STAB Position: Q1 2022 in Review
Potomac Capital Management sold out of Statera Biopharma (STAB) in Q1 2022, closing a stake of 381,900 shares — an estimated $878K sold.
Potomac Capital Management first reported a position in STAB in Q4 2021 and held it in 1 quarter. The position peaked at $878K in Q4 2021. 33 funds tracked by Wall St. Rank hold STAB as of Q1 2022.
- Potomac Capital Management reported no remaining Statera Biopharma position as of Q1 2022 after selling out during the quarter.
- Potomac Capital Management sold 381,900 Statera Biopharma shares in Q1 2022, an estimated $878K.
- Potomac Capital Management first reported a position in Statera Biopharma in Q4 2021 and held it in 1 quarter.
- Potomac Capital Management's Statera Biopharma position peaked at $878K in Q4 2021.
- 33 funds tracked by Wall St. Rank held Statera Biopharma as of Q1 2022.
Based on Potomac Capital Management's 13F filing for Q1 2022, filed 27 Apr 2022.